Comparison of Outpatient Antibiotic Therapy (OPAT) Use of Daptomycin, Linezolid, Quinupristin/Dalfopristin, Tigecycline, and Vancomycin in Physician-Operated Infusion Centers (POICs)

October 25, 2008

Authors:
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.